Cerus to Present at the Wedbush 2013 Life Sciences Management Access Conference on August 14, 2013
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NAS: CERS) announced today that William "Obi" Greenman, Cerus' president and chief executive officer, is scheduled to present a corporate update at the Wedbush 2013 Life Sciences Management Access Conference in New York at 8:35 am ET on Wednesday, August 14, 2013.
A live webcast of the presentation will be available from the Investor Relations page of the Cerus web site at http://www.cerus.com/ir. A replay will be available for approximately two weeks following the completion of the event.
Cerus Corporation is a biomedical products company focused in the field of blood safety. The company's INTERCEPT Blood System has been demonstrated to inactivate a broad range of viruses, bacteria and parasites that may be present in donated blood, including established threats such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as influenza, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development. See http://www.cerus.com for more information.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.
Lainie Corten, 925-288-6319
Senior Director, Global Marketing & Investor Relations
KEYWORDS: United States North America California New York
The article Cerus to Present at the Wedbush 2013 Life Sciences Management Access Conference on August 14, 2013 originally appeared on Fool.com.